Ultiva
NDC 67457-913, Remifentanil Hydrochloride, injection, powder, lyophilized, for solution, from Mylan Institutional LLC.
- Product NDC
- 67457-913
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020630
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/67457-913 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REMIFENTANIL HYDROCHLORIDE1 mg/mL
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-913-02 | 67457091302 | 10 VIAL, GLASS in 1 CARTON (67457-913-02) / 5 mL in 1 VIAL, GLASS (67457-913-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4dbcb8f9-1987-4b66-bd2f-d251fda0be10
Use it
Look up 67457-913 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-913 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-913. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.